Vous êtes sur la page 1sur 1

42418 Federal Register / Vol. 71, No.

143 / Wednesday, July 26, 2006 / Notices

should be addressed, in quintuplicate, Any such written comments or good.larry@dol.gov. Statements received
to the Deputy Assistant Administrator, objections being sent via regular mail on or before August 3, 2006 will be
Office of Diversion Control, Drug should be addressed, in quintuplicate, included in the record of the meeting.
Enforcement Administration, to the Deputy Assistant Administrator, Individuals or representatives of
Washington, DC 20537, Attention: DEA Office of Diversion Control, Drug organizations wishing to address the
Federal Register Representative/ODL; or Enforcement Administration, Working Group should forward their
any being sent via express mail should Washington, DC 20537, Attention: DEA requests to the Executive Secretary or
be sent to DEA Headquarters, Attention: Federal Register Representative/ODL; or telephone (202) 693–8668. Oral
DEA Federal Register Representative/ any being sent via express mail should presentations will be limited to 20
ODL, 2401 Jefferson-Davis Highway, be sent to DEA Headquarters, Attention: minutes, time permitting, but an
Alexandria, Virginia 22301; and must be DEA Federal Register Representative/ extended statement may be submitted
filed no later than August 25, 2006. ODL, 2401 Jefferson-Davis Highway, for the record. Individuals with
This procedure is to be conducted Alexandria, Virginia 22301; and must be disabilities who need special
simultaneously with, and independent filed no later than September 25, 2006. accommodations should contact Larry
of, the procedures described in 21 CFR Dated: July 10, 2006. Good by August 3, 2006 at the address
1301.34(b), (c), (d), (e) and (f). As noted Joseph T. Rannazzisi, indicated.
in a previous notice published in the Deputy Assistant Administrator, Office of Signed at Washington, DC, this 18th day of
Federal Register on September 23, 1975, Diversion Control, Drug Enforcement July, 2006.
(40 FR 43745–46), all applicants for Administration. Ann L. Combs,
registration to import a basic class of [FR Doc. E6–11933 Filed 7–25–06; 8:45 am] Assistant Secretary, Employee Benefits
any controlled substance listed in BILLING CODE 4410–09–P Security Administration.
Schedule I or II are, and will continue [FR Doc. 06–6522 Filed 7–25–06; 8:45 am]
to be required to demonstrate to the BILLING CODE 4510–29–M
Deputy Assistant Administrator, Office DEPARTMENT OF LABOR
of Diversion Control, Drug Enforcement
Administration, that the requirements Employee Benefits Security DEPARTMENT OF LABOR
for such registration pursuant to 21 Administration
U.S.C. 958(a), 21 U.S.C. 823(a), and 21 Employee Benefits Security
CFR 1301.34(b), (c), (d), (e) and (f) are Advisory Council on Employee Welfare Administration
satisfied. and Pension Benefit Plans Working
Group on Health Information Advisory Council on Employee Welfare
Dated: July 19, 2006. Technology; Notice of Meeting and Pension Benefit Plans Working
Joseph T. Rannazzisi, Group on Plan Asset Rules,
Deputy Assistant Administrator, Office of Pursuant to the authority contained in
Exemptions, and Cross Trading;
Diversion Control, Drug Enforcement Section 512 of the Employee Retirement
Notice of Meeting
Administration. Income Security Act of 1974 (ERISA), 29
[FR Doc. E6–11932 Filed 7–25–06; 8:45 am] U.S.C. 1142, the Working Group Pursuant to the authority contained in
BILLING CODE 4410–09–P
assigned by the Advisory Council on Section 512 of the Employee Retirement
Employee Welfare and Pension Benefit Income Security Act of 1974 (ERISA), 29
Plans to study the issue of Health U.S.C. 1142, the Working Group
DEPARTMENT OF JUSTICE Information Technology will hold an assigned by the Advisory Council on
open public meeting on August 10, Employee Welfare and Pension Benefit
Drug Enforcement Administration 2006. Plans to study the issue of Plan Asset
The session will take place in Room Rules, Exemptions, and Cross Trading
Manufacturer of Controlled N4437 A–C, U.S. Department of Labor, will hold an open public meeting on
Substances; Notice of Application 200 Constitution Avenue, NW., August 11, 2006.
Washington, DC 20210. The purpose of The session will take place in Room
Pursuant to section 1301.33(a) of Title the open meeting, which will run from N4437 A–C, U.S. Department of Labor,
21 of the Code of Federal Regulations 9:45 a.m. to approximately 5 p.m., with 200 Constitution Avenue, NW.,
(CFR), this is notice that on February 7, a one hour break for lunch, is for Washington, DC 20210. The purpose of
2006, Polaroid Corporation, 1265 Main Working Group members to hear the open meeting, which will run from
Street, Building W6, Waltham, testimony from invited witnesses. The 9 a.m. to approximately 5 p.m., with a
Massachusetts 02454, made application Working Group will study what is one hour break for lunch, is for Working
by renewal to the Drug Enforcement necessary to encourage the widespread Group members to hear testimony from
Administration (DEA) to be registered as adoption of health information invited witnesses. The working group
a bulk manufacturer of 2,5- technology using common standards will study (1) the current applicability
Dimethoxyamphetamine (7396), a basic and how the federal government can of the 1987 plan asset regulation, to
class of controlled substance listed in work with the private sector and determine whether the regulation
Schedule I. industry to accomplish this objective. should be modified or whether other
The company plans to manufacture Organizations or members of the DOL action is appropriate to clarify the
the listed controlled substance in bulk public wishing to submit a written existing regulation, and (2) cross
for conversion into non-controlled statement pertaining to the topic may do trading, to determine whether the DOL
substance. so by submitting 25 copies on or before should issue broader exemptive relief
Any other such applicant and any August 3, 2006 to Larry Good, Executive for cross-trading.
sroberts on PROD1PC70 with NOTICES

person who is presently registered with Secretary, ERISA Advisory Council, Organizations or members of the
DEA to manufacture such a substance U.S. Department of Labor, Suite N– public wishing to submit a written
may file comments or objections to the 5623, 200 Constitution Avenue, NW., statement pertaining to the topic may do
issuance of the proposed registration Washington, DC 20210. Statements also so by submitting 25 copies on or before
pursuant to 21 CFR 1301.33(a). may be submitted electronically to August 3, 2006 to Larry Good, Executive

VerDate Aug<31>2005 17:16 Jul 25, 2006 Jkt 208001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\26JYN1.SGM 26JYN1

Vous aimerez peut-être aussi